Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.

The most serious cases of lymphoma can be treated with a drug made by engineering a patient’s immune cells to target tumors. But CAR-T therapy doesn’t work in all cases. In securing its first FDA drug ...

ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that has ...